Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity

E-ISSN： 1875-6697|11|4|361-373

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.11, Iss.4, 2016-01, pp. : 361-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urotensin-II Receptor Antagonists

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite

Non-peptidic urotensin-II receptor modulators

By Jin Jian Douglas Stephen A

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 467-479

Informa Healthcare

Access to resources Recommend Favorite

Recent Structure-Activity Studies of the Peptide Hormone Urotensin-II, a Potent Vasoconstrictor

Current Medicinal Chemistry, Vol. 11, Iss. 8, 2004-04 ,pp. : 969-979

Bentham Science Publishers

Access to resources Recommend Favorite

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors

Current Cancer Drug Targets, Vol. 17, Iss. 2, 2017-01 ,pp. : 109-121

Bentham Science Publishers

Access to resources Recommend Favorite

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats

By Gendron Gabrielle Simard Bryan Gobeil Jr. Fernand Sirois Pierre D'Orléans-Juste Pedro Regoli Domenico

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 1, 2004-01 ,pp. : 16-21

NRC Research Press

Access to resources Recommend Favorite